Natalizumab treatment of progressive multiple sclerosis reduces inflammation and tissue damage - results of a phase 2A proof-of-concept study

J. Romme Christensen, R. Ratzer, L. Bornsen, E. Garde, Mark Lyksborg, H. R. Siebner, T. B. Dyrby, P. S. Sørensen, F. Sellebjerg

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalMultiple Sclerosis
Volume18
Issue number4 supplement
Pages (from-to)514-515
ISSN1352-4585
DOIs
Publication statusPublished - 2012
Externally publishedYes
Event28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis - Lyon, France
Duration: 10 Oct 201213 Oct 2012
http://www.ectrims-congress.eu/2012.html

Conference

Conference28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
CountryFrance
CityLyon
Period10/10/201213/10/2012
Internet address

Cite this